Gilead registers two Phase 2 trials: PBC combo study and weekly oral HIV regimenSep 25Weekly roundup, 2 itemsGilead SciencesGS-3242
Gilead reports Q2 2026 results with three FDA approvals, three positive Phase 3 readoutsAug 4Quarterly updateGilead Sciences
Sign inSign in